Frequency of MET exon 14 skipping mutations in non-small cell lung cancer according to technical approach in routine diagnosis: results from a real-life cohort of 2,369 patients

BACKGROUND: Mesenchymal epithelial transition receptor (MET) alterations, including MET exon 14 skipping mutation, are oncogenic in non-small cell lung cancer (NSCLC) and may confer sensitivity to targeted therapy. Given the rarity and the diversity of exon 14 skipping mutations, diagnosis may be ch...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Thorac Dis
Main Authors: Champagnac, Anne, Bringuier, Pierre-Paul, Barritault, Marc, Isaac, Sylvie, Watkin, Emmanuel, Forest, Fabien, Maury, Jean-Michel, Girard, Nicolas, Brevet, Marie
Formato: Artigo
Idioma:Inglês
Publicado em: AME Publishing Company 2020
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7330338/
https://ncbi.nlm.nih.gov/pubmed/32642122
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2020.04.21
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados